Prelude Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-75,227
| Closed | -$2.03M | – | 1593 |
|
|
2024
Q2 | $2.03M | Buy |
+75,227
| New | +$1.56M | 0.14% | 184 |
|
|
2023
Q4 | – | Sell |
-15,371
| Closed | -$230K | – | 1434 |
|
|
2023
Q3 | $230K | Buy |
+15,371
| New | +$320K | 0.02% | 820 |
|
|
2023
Q2 | – | Sell |
-11,784
| Closed | -$461K | – | 1411 |
|
|
2023
Q1 | $461K | Sell |
11,784
-10,721
| -48% | -$524K | 0.03% | 492 |
|
|
2022
Q4 | $1.19M | Buy |
22,505
+12,789
| +132% | +$623K | 0.06% | 321 |
|
|
2022
Q3 | $437K | Buy |
9,716
+1,186
| +14% | +$51K | 0.02% | 704 |
|
|
2022
Q2 | $310K | Buy |
8,530
+2,113
| +33% | +$76.8K | 0.01% | 1050 |
|
|
2022
Q1 | $265K | Sell |
6,417
-3,348
| -34% | -$118K | 0.01% | 1121 |
|
|
2021
Q4 | $416K | Sell |
9,765
-799
| -8% | -$40K | 0.01% | 1124 |
|
|
2021
Q3 | $581K | Buy |
10,564
+5,135
| +95% | +$269K | 0.01% | 820 |
|
|
2021
Q2 | $260K | Sell |
5,429
-144
| -3% | -$7.34K | 0.01% | 1262 |
|
|
2021
Q1 | $282K | Buy |
5,573
+299
| +6% | +$16.6K | 0.01% | 1183 |
|
|
2020
Q4 | $332K | Sell |
5,274
-326
| -6% | -$20.2K | 0.01% | 877 |
|
|
2020
Q3 | $376K | Hold |
5,600
| – | – | 0.02% | 500 |
|
|
2020
Q2 | $235K | Buy |
+5,600
| New | +$215K | 0.01% | 696 |
|
|
2020
Q1 | – | Sell |
-93
| Closed | -$4K | – | 2150 |
|
|
2019
Q4 | $4K | Sell |
93
-315
| -77% | -$11K | ﹤0.01% | 1795 |
|
|
2019
Q3 | $13K | Buy |
+408
| New | +$16.3K | ﹤0.01% | 1462 |
|
Other funds holding SILK
Prelude Capital Management's SILK Position: Q3 2024 in Review
Prelude Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 75,227 shares — an estimated $2.03M sold.
Prelude Capital Management first reported a position in SILK in Q3 2019 and held it in 16 quarters. The position peaked at $2.03M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Prelude Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Prelude Capital Management sold 75,227 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $2.03M.
- Prelude Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 16 quarters.
- Prelude Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $2.03M in Q2 2024.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.